Dihydrocholesterol is a lipid of Sterol Lipids (ST) class. Dihydrocholesterol is associated with abnormalities such as Exanthema, Morphologically altered structure, protrusion, Dehydration and Xanthoma. The involved functions are known as Regulation, Biochemical Pathway, Methylation, Metabolic Inhibition and Biosynthetic Pathways. Dihydrocholesterol often locates in envelope, Mitochondria, Lipid Bilayers, Host Cell and Membrane. The associated genes with Dihydrocholesterol are GRAP2 gene, PTP4A2 gene, HSD3B7 gene, MBD2 gene and IGF2BP3 gene. The related lipids are Sterols, Cardiolipins, Pregnanes, 7-hydroxy-4-cholesten-3-one and Hydroxycholesterols. The related experimental models are Mouse Model.
PMID | Journal | Published Date | Author | Title |
---|---|---|---|---|
11796362 | Antimicrob. Agents Chemother. | 2002 | Rodrigues JC et al. | Ultrastructural and biochemical alterations induced by 22,26-azasterol, a delta(24(25))-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis. |
14766559 | Appl. Environ. Microbiol. | 2004 | Isobe KO et al. | Effect of environmental factors on the relationship between concentrations of coprostanol and fecal indicator bacteria in tropical (Mekong Delta) and temperate (Tokyo) freshwaters. |
16436059 | FEMS Microbiol. Lett. | 2006 | PalmiƩ-Peixoto IV et al. | Effects of sterol biosynthesis inhibitors on endosymbiont-bearing trypanosomatids. |
26806364 | J. Pediatr. | 2016 | Whiteside W et al. | Altered Cholesterol Metabolism and Hypocholesterolemia in Patients with Single Ventricle following Fontan Palliation. |
26687702 | J Clin Lipidol | 2015 Nov-Dec | Dayspring TD et al. | Biomarkers of cholesterol homeostasis in a clinical laboratory database sample comprising 667,718 patients. |
26228071 | Mar. Pollut. Bull. | 2015 | Lyons BP et al. | Microbial water quality and sedimentary faecal sterols as markers of sewage contamination in Kuwait. |
26022817 | J. Am. Coll. Cardiol. | 2015 | Silbernagel G et al. | Intestinal cholesterol absorption, treatment with atorvastatin, and cardiovascular risk in hemodialysis patients. |